BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11825330)

  • 1. Botulinum toxin for the treatment of cervical dystonia.
    Tintner R; Jankovic J
    Expert Opin Pharmacother; 2001 Dec; 2(12):1985-94. PubMed ID: 11825330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal dystonia: the role of botulinum toxin.
    Tintner R; Jankovic J
    Curr Neurol Neurosci Rep; 2001 Jul; 1(4):337-45. PubMed ID: 11898539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cervical dystonia with botulinum toxin.
    Jankovic J
    Mov Disord; 2004 Mar; 19 Suppl 8():S109-15. PubMed ID: 15027062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin therapy for cervical dystonia.
    Walker FO
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):749-66, vi. PubMed ID: 14580035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ptosis as a remote effect of therapeutic botulinum toxin B injection.
    Racette BA; Lopate G; Good L; Sagitto S; Perlmutter JS
    Neurology; 2002 Nov; 59(9):1445-7. PubMed ID: 12427903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A.
    Sheean GL; Lees AJ
    J Neurol Neurosurg Psychiatry; 1995 Dec; 59(6):601-7. PubMed ID: 7500097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical dystonia pathophysiology and treatment options.
    Velickovic M; Benabou R; Brin MF
    Drugs; 2001; 61(13):1921-43. PubMed ID: 11708764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related botulinum toxin effects on muscle fiber conduction velocity in non-injected muscles.
    Lange F; van Weerden TW; van der Hoeven JH
    Clin Neurophysiol; 2007 Nov; 118(11):2398-403. PubMed ID: 17897878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cervical dystonia with botulinum toxins.
    Comella CL; Thompson PD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():16-20. PubMed ID: 16417593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin therapy for cervical dystonia.
    Jankovic J
    Neurotox Res; 2006 Apr; 9(2-3):145-8. PubMed ID: 16785112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological effects of botulinum toxin in spasticity.
    Gracies JM
    Mov Disord; 2004 Mar; 19 Suppl 8():S120-8. PubMed ID: 15027064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Craniocervical dystonia: clinical and pathophysiological features.
    Colosimo C; Suppa A; Fabbrini G; Bologna M; Berardelli A
    Eur J Neurol; 2010 Jul; 17 Suppl 1():15-21. PubMed ID: 20590803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type B: a new injectable treatment for cervical dystonia.
    Brashear A
    Expert Opin Investig Drugs; 2001 Dec; 10(12):2191-9. PubMed ID: 11772315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of cervical dystonia with botulinum toxins.
    Comella CL
    J Neural Transm (Vienna); 2008; 115(4):579-83. PubMed ID: 17994181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a new bulk toxin of botulinum toxin in cervical dystonia: a blinded evaluation.
    Racette BA; McGee-Minnich L; Perlmutter JS
    Clin Neuropharmacol; 1999; 22(6):337-9. PubMed ID: 10626093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin: a deadly substance with great therapeutic effect.
    Holmes S
    Prof Nurse; 2003 Oct; 19(2):85-7. PubMed ID: 14593781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New therapeutic indications for botulinum toxins.
    Cordivari C; Misra VP; Catania S; Lees AJ
    Mov Disord; 2004 Mar; 19 Suppl 8():S157-61. PubMed ID: 15027069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin in movement disorders.
    Jankovic J
    Curr Opin Neurol; 1994 Aug; 7(4):358-66. PubMed ID: 7952246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.